Does Semaglutide or Tirzepatide Cause Hair Loss?

For a while, GLP-1-related hair loss was mostly anecdotal — forum posts and before-and-after threads, with no rigorous data behind it. That has changed. Two large cohort studies published in the *Journal of the American Academy of Dermatology* in the past two years now put real numbers on the association, and it is worth taking seriously rather than dismissing as internet noise.

What the data actually shows

A 2025 retrospective cohort study in JAAD compared patients on GLP-1 receptor agonist medications against matched controls and found a significantly elevated risk of new hair loss diagnoses among GLP-1 users¹. A follow-up 2026 study using the TriNetX health-records network — a much larger, real-world dataset spanning millions of patient records — confirmed the pattern: new-onset hair loss was significantly more common among people newly started on semaglutide or tirzepatide than among matched comparison groups². Two independent, large-sample cohort studies landing on the same conclusion is a meaningfully stronger signal than the single case reports and small case series that used to be the only data available.

The likely mechanism: it's the weight loss, not the drug directly

Neither study found evidence that semaglutide or tirzepatide damages hair follicles directly. The leading explanation is a well-established phenomenon called **telogen effluvium** — a temporary, diffuse shedding triggered by a significant physiological stressor, and rapid or substantial weight loss is a well-documented trigger of it, independent of how the weight loss was achieved. Hair follicles are metabolically demanding tissue; a body under caloric and nutritional stress can push a larger-than-usual share of hair follicles into the "resting" (telogen) phase simultaneously, which shows up three to six months later as noticeably increased shedding. This is the same mechanism seen after bariatric surgery, crash diets, and other causes of fast weight loss — it is not unique to GLP-1s, but GLP-1s are, by design, very effective at producing the fast weight loss that triggers it.

Is it permanent?

Telogen effluvium is, by definition, temporary — the shed follicles typically re-enter their growth phase once the triggering stress resolves or the body adapts, and hair density recovers over months. That said, neither cohort study followed patients long enough to report definitive regrowth timelines, and any hair loss that seems to be accelerating, patchy rather than diffuse, or not improving after the weight has stabilized deserves an actual dermatology evaluation rather than an assumption that it will resolve on its own.

What actually helps

The evidence-based basics apply here as they do for weight-loss-triggered hair shedding generally: adequate protein intake (a real risk during rapid, appetite-suppressed weight loss), avoiding severe caloric deficits beyond what your titration schedule calls for, and iron and vitamin D levels checked if shedding is significant — deficiencies in both are common causes of hair loss that can compound a telogen-effluvium episode and are straightforward to test for. If you are titrating aggressively and losing weight very fast, our titration planner can help you see whether your pace is on the labeled schedule or running ahead of it — a slower, label-consistent titration is one lever within your control.

What this means for choosing a provider

This is exactly the kind of side effect where ongoing support after your first shipment — not just the prescription itself — matters. A provider whose care ends at checkout will not catch nutritional gaps or flag when shedding warrants a dermatology referral; one that stays engaged through titration will. Member support is a scored factor in our Verdict Score methodology for precisely this reason — see how providers compare in the ranked reviews.

This is editorial information, not medical advice. If you are experiencing significant or patchy hair loss, talk to a dermatologist or your prescribing clinician.